News | Blogs | Healthcare | Consulting
Contact: info@ipharmacenter.com
ESMO 2020
Novartis Beovu demonstrated non-inferiority vs. aflibercept in the PEP and superiority in SEP
Bayer submitted vericiguat for market authorization in China